(Q38487007)

3 September 2017

Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element (English)

1 reference

3 September 2017

Papapetrou EP

1

1 reference

3 September 2017

Ziros PG

2

1 reference

3 September 2017

Micheva ID

3

1 reference

3 September 2017

Zoumbos NC

4

1 reference

3 September 2017

Athanassiadou A

5

1 reference

3 September 2017

1 January 2006

1 reference

3 September 2017

1 reference

3 September 2017

13

1 reference

3 September 2017

1

1 reference

3 September 2017

40-51

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302593

3 September 2017

0 references

cites work

Gene therapy for inherited disorders of haematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Therapeutic applications for hematopoietic stem cell gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Development of gene therapy for blood disorders by gene transfer into haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Genetic manipulation of hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Silencing of gene expression: implications for design of retrovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Chance or necessity? Insertional mutagenesis in gene therapy and its consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Chromosome-based vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Episomal vectors for gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Mechanisms of transcriptional regulation of cellular genes by SV40 large T- and small T-antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Biological significance of unwinding capability of nuclear matrix-associating DNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

An episomally replicating vector binds to the nuclear matrix protein SAF-A in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Induction of Erythroid-Specific Expression in Murine Erythroleukemia (MEL) Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Selective extraction of polyoma DNA from infected mouse cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

LCR-mediated, long-term tissue-specific gene expression within replicating episomal plasmid and cosmid vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between transcription and replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Stable expression of selectable genes introduced into human hematopoietic stem cells by electric field-mediated DNA transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Efficient expression of foreign genes in human CD34(+) hematopoietic precursor cells using electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Gene transfer into human umbilical cord blood-derived CD34+ cells by particle-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

An episomal mammalian replicon: sequence-independent binding of the origin recognition complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Gene therapy progress and prospects: episomally maintained self-replicating systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Epstein-Barr virus vectors for gene expression and transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic beta-globin in cultured murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

7 January 2021

High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

7 January 2021

Successful transfer of ADA gene in vitro into human peripheral blood CD34+ cells by transfecting EBV-based episomal vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

7 January 2021

Synthetic DNA delivery systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302593

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302593

1 reference

3 September 2017

1 reference